The Most Expensive Way to Be Wrong

Founders model what a big pre-seed buys them if it works. Almost no one models what it costs them if it does not.

We were talking this past week with Alex Perelman, a founder coach who has started four companies and been through YC twice, about a pattern he keeps seeing: founders raising bigger pre-seeds before they have a stronger signal, then mistaking the size of the round for the strength of the company.

What founders call a pre-seed has changed, and the data makes it obvious. Among SAFEs that raised at least a million dollars, the average deal reached $1.4M in 2025, up from $1.1M in 2024. Carta puts the median seed fundraising amount in 2024 at $2.5M.

But the more interesting story is the split underneath it. More than a third of pre-seed rounds in the last quarter of 2025 came in under $250K. The market is pulling apart into the lean and the loaded, and the loaded ones are increasingly raising big before they have proven anything.

Founders treat the bigger number as a win. But it carries a cost they do not anticipate.

Before you have early adopters, a bigger round does not lower your risk. It raises the price of being wrong.

A big pre-seed is not dangerous because the money is bad. It is dangerous because it can turn a cheap learning cycle into a multi-year commitment.

Everyone models the upside. Nobody models the downside.

When a founder decides how much to raise, the math is almost always about the good case. What does $3M buy that $300K does not? More engineers, more runway, more go-to-market. Every line of that math quietly assumes the thing works.

The case that actually decides your life is the other one. What does the money cost you if it does not work?

Run that math instead.

Raise $300K. It lasts you twelve months. You stay close to the customer because there is nobody else to do it, you ship, you test the thesis, and at the end of the year, the signal is still not there. That is a painful outcome. It is also a cheap one. You spent twelve months and $300K to learn that the thesis was wrong. You have a working prototype, a real story, and most of your time and savings still intact. You can walk into your next thing, or your next raise, almost immediately. Being wrong costs you a year.

Now raise $3M on the same unproven thesis. It lasts you two, maybe three years. You hire the team that the deck promised. You build the broad version of the product. And the entire time, the signal is lukewarm. Customers are interested but not urgent. Pilots are active but not expanding. Nothing is failing outright, so nothing forces you to stop. At the end of it, you reach the same conclusion you would have reached in the first scenario: this is not working, except now it costs you three years, a team you have to let go, and a cap table priced for an outcome that never came.

Same answer. Wildly different price.

That is the part founders miss. The size of your raise is the size of the bill when you are wrong. And before there is proof, you do not yet know whether you are wrong.

You can see the later-stage version of the same mistake in the companies that raised enormous rounds before demand was proven. Quibi raised $1.75B before launch, projected seven million subscribers in its first year, landed around five hundred thousand, and was gone in six months. Fast reportedly burned through more than $120M of investor money against roughly $600K in revenue. Color Labs raised $41M before its app was ever in users’ hands, then opened to two-star reviews. These are not pre-seed stories. They are what the same mistake looks like with two more zeros. Capital can let a team be wrong for a very long time, very loudly, before the market ever says yes.

Lukewarm is the trap. Not failure.

We made this point in When Promising Becomes Dangerous. The startups that quietly kill founders are not the ones where nothing works. Those are clear. You run out of money, you face the truth, you move on. The dangerous ones are where something is kind of working, and keeps kind of working, for years.

Failure gives you an answer. Lukewarm permits you to keep going.

A big round is what funds the “for years” part.

A small round has a forcing function built into it. The money runs out. That deadline is brutal, but it is honest. It makes you confront whether the signal is real while you still have the time and the energy to do something about it.

A big round removes that forcing function at the exact moment you need it most. You can sustain a lukewarm signal for a long time because you can afford to. You can keep hiring against it, keep building against it, keep telling yourself the next feature or the next segment is the one. The money becomes the reason you stop looking for the truth.

Paul Graham calls the end state the fatal pinch: default, dead, slow growth, and not enough time to fix it. The cruel part is that founders rarely see it coming, because the money still in the bank feels like proof they are fine.

Running out of money forces clarity. A big round lets you buy your way out of clarity, and clarity is the one thing you cannot afford to avoid this early.

The quieter version is more common, and it does not need a famous logo to go wrong. Noogata raised $28M and counted PepsiCo and Colgate as clients, the kind of names that look like proof, then failed to hit its milestones, could not raise again, and wound down. Brand-name pilots are not a fundable business, and capital is very good at hiding the difference. A logo is not the same thing as pull. A pilot is not the same thing as urgency. One founder put the trap precisely: too expensive for new investors, without the traction to justify the next round. That is not a problem money solves. It is one money that creates.

The thing you are actually spending is time.

Money is a recoverable resource. You can raise again. You can take a job and rebuild your savings. Founders treat capital as a scarce thing because it is the thing they are negotiating over. It is not the scarce thing.

The scarce things are your time, your optionality, and the specific window you are building into.

A bigger raise on an untested thesis commits more of all three to a bet you have not validated yet. This is the part that should sit with you. You are the only person at that table underwriting the downside with your life. Your investor wrote a check as one position in a portfolio. That is the model, and it is the right one. They are supposed to diversify. You are not diversified. If the company does not work, they lose one bet. You lose years.

That is not a reason to distrust investors. It is a reason to remember that the person with the most to lose from a bigger round is you, and to size the round like it.

Why being wrong was cheap for us

At Moichor we started with bloodwork for humans. Within about a week and a half of talking to vets, pet owners, and agriculture experts, we had pivoted twice, first to livestock, then to pets. We have told that story before as a story about listening to customers. It is also a story about cost. The reason we could listen was not just that we were open-minded. It was that we had not made the wrong answer expensive yet.

Those pivots were cheap because we had not over-committed capital to the first thesis. We had not hired a team to build the human product. We had not built the broad version of anything. Changing direction cost us a week and a few honest conversations among the three of us. It cost nothing on a cap table, and it cost nobody their job.

If we had raised a few million on the human-bloodwork thesis and staffed up against it first, that same pivot is not a Tuesday. It is a layoff, a write-down, and a very uncomfortable conversation with investors who priced the round on the thing you are now walking away from. Same insight. Same correctness. Completely different price for acting on it.

We raised reasonably at every stage, and what that bought us, every time, was the ability to be wrong quickly and cheaply. Things always took longer than we modeled. Being able to absorb that without a near-death event was worth more than any amount of extra runway.

Identified early adopters change the math

This is the line that matters, because the point is not raise small forever.

Before demand is proven, a big round is a bet on a thesis. You are spending money to find out whether you are right, and the more you spend, the more it costs to find out you were not.

After you have early adopters, real people with an urgent and expensive problem who are pulling the product out of your hands, a big round becomes something else entirely. Now you are not buying discovery. You are buying acceleration of a thing that already works. The same $3M that is reckless before the pull exists is exactly right after it.

So the rule is not a number. It is a ratio. Match the size of your raise to the strength of your proof. When the signal is thin, raise the amount that keeps being wrong cheap. When the pull is undeniable, raise the amount that makes being right fast.

Raise to match signal, not ambition.

We argued the small end of that in Raise Small, Stay Sharp. This is the other half of the same argument. Raising less is not discipline for its own sake. It is refusing to make being wrong any more expensive than it has to be, until you have earned the right to spend more.

Final thought

You cannot control whether your first thesis is right. Most are not.

What you can control is how expensive it becomes to find out.

Before early adopters, raise the number that keeps being wrong survivable. Once the signal is undeniable, raise the number that makes being right fast.